Our Solutions



  • E-Bulletin

    October 2018

    Oct 17, 2018

    The Impact of Biosimilars on Drug Development and Key Study Considerations

  • E-Bulletin

    Customized Biostatistics Services

    Aug 22, 2018

    No matter the scale and scope of your study, whether it's local or international, Altasciences offers customized biostatistics services that suit your needs.

  • E-Bulletin

    Drug-Drug Interaction Studies

    Aug 10, 2018

    Do you have a Drug-Drug Interaction study in your pipeline? See the unique advantages Altasciences offers to complete quality DDI studies on time and cost-effectively.

  • E-Bulletin

    July 2018

    Jul 23, 2018

    Steps the FDA has taken to limit the misuse and abuse of prescription drugs, our tips on how to conduct a Human Abuse Potential (HAP) study, and a recent HAP case study.

  • E-Bulletin

    May 2018

    May 22, 2018

    FAQs on Clinical Studies Involving Oligonucleotides

  • E-Bulletin

    March 2018

    Mar 12, 2018

    Cannabis-based medicinal products to revolutionize traditional medicine

  • E-Bulletin

    February 2018

    Feb 28, 2018

    Ligand Binding and Mass Spectrometry — Guiding You to the Appropriate Bioanalytical Platform/Approach

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.